ebomi
Colour theme
Sign in
Insider · CIK 0001779453

Epiq Capital Group, LLC

CIK 0001779453 Name as filed on the most recent filing

Filed as Epiq Capital Group, LLC (12)

31 transaction lines · from 12 filings · filed 2019-06-14 to 2022-05-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-05-13 P, Open-market purchase Applied Molecular Transport Inc.AMTI 124,124, acquired Open Form 4 filing 0001667731-22-000196
2022-05-12 P, Open-market purchase Applied Molecular Transport Inc.AMTI 125,634, acquired Open Form 4 filing 0001667731-22-000196
2021-11-17 P, Open-market purchase Applied Molecular Transport Inc.AMTI 159,684, acquired Open Form 4 filing 0001667731-21-000314
2021-11-16 P, Open-market purchase Applied Molecular Transport Inc.AMTI 90,298, acquired Open Form 4 filing 0001667731-21-000314
2021-02-05 P, Open-market purchase Lucira Health, Inc.LHDX 58,849,988, acquired Open Form 4 filing 0001779453-21-000004
2020-06-12 P, Open-market purchase Cortexyme, Inc.CRTX 107,506, acquired Open Form 4 filing 0001779453-20-000005
2020-06-11 P, Open-market purchase Cortexyme, Inc.CRTX 292,512, acquired Open Form 4 filing 0001779453-20-000005
2020-06-09 P, Open-market purchase Applied Molecular Transport Inc.AMTI 2 lines 38,080,000, acquired Open Form 4 filing 0001779453-20-000004
2020-05-22 P, Open-market purchase Cortexyme, Inc.CRTX 116,552, acquired Open Form 4 filing 0001779453-20-000002
2020-05-21 P, Open-market purchase Cortexyme, Inc.CRTX 29,016, acquired Open Form 4 filing 0001779453-20-000002
2020-05-20 P, Open-market purchase Cortexyme, Inc.CRTX 2 lines 352,605, acquired Open Form 4 filing 0001779453-20-000002
2019-08-21 P, Open-market purchase Cortexyme, Inc.CRTX 2 lines 51,105, acquired Open Form 4 filing 0001779453-19-000007
2019-08-21 P, Open-market purchase Cortexyme, Inc.CRTX 2 lines 51,105, acquired Open Form 4 filing 0001779453-19-000003
2019-08-20 P, Open-market purchase Cortexyme, Inc.CRTX 2 lines 74,758, acquired Open Form 4 filing 0001779453-19-000007
2019-08-20 P, Open-market purchase Cortexyme, Inc.CRTX 2 lines 74,758, acquired Open Form 4 filing 0001779453-19-000003
2019-08-19 P, Open-market purchase Cortexyme, Inc.CRTX 55,640, acquired Open Form 4 filing 0001779453-19-000006
2019-08-19 P, Open-market purchase Cortexyme, Inc.CRTX 55,640, acquired Open Form 4 filing 0001779451-19-000001
2019-08-16 P, Open-market purchase Cortexyme, Inc.CRTX 18,460, acquired Open Form 4 filing 0001779453-19-000006
2019-08-16 P, Open-market purchase Cortexyme, Inc.CRTX 18,460, acquired Open Form 4 filing 0001779451-19-000001
2019-05-10 P, Open-market purchase Cortexyme, Inc.CRTX 3 lines 232,056, acquired Open Form 4 filing 0001779453-19-000005
2019-05-10 P, Open-market purchase Cortexyme, Inc.CRTX 3 lines 232,056, acquired Open Form 4 filing 0001779453-19-000002

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. EPIQ Capital Group, LLC, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001779453

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.